Publications

NAOMI: The trials and tribulations of implementing a heroin assisted treatment study in North America

1 January 2009

Opioid addiction is a chronic, relapsing disease and remains a major public health challenge. Despite important expansions of access to conventional treatments, there are still significant proportions of affected individuals who remain outside the reach of the current treatment system and who contribute disproportionately to health care and criminal justice costs as well as to public disorder associated with drug addiction.

The main objective of the NAOMI Study is to determine whether the closely supervised provision of injectable, pharmaceutical-grade opioid agonist is more effective than methadone alone in recruiting, retaining, and benefiting chronic, opioid-dependent, injection drug users who are resistant to current standard treatment options.

Related Profiles

  • Nancy Laliberté
  • Martin T. Schechter
  • Eugenia Oviedo-Joekes
  • Candice C.Gartry